OPTIPHARM

The current price of 153710 is 6680 KRW — it has increased by 0.15% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange OPTIPHARM stocks are traded under the ticker 153710.

153710 stock is 2.73% volatile and has beta coefficient of 0.48. Check out the list of the most volatile stocks — is OPTIPHARM there?

Yes, you can track OPTIPHARM financials in yearly and quarterly reports right on TradingView.

153710 stock has risen by 4.05% compared to the previous week, the month change is a 6.31% fall, over the last year OPTIPHARM has showed a 15.76% decrease.

153710 net income for the last quarter is ‪−141.41 M‬ KRW, while the quarter before that showed ‪−710.46 M‬ KRW of net income which accounts for 80.10% change. Track more OPTIPHARM financial stats to get the full picture.

No, 153710 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, 153710 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OPTIPHARM stock right from TradingView charts — choose your broker and connect to your account.

153710 reached its all-time high on Aug 21, 2020 with the price of 31150 KRW, and its all-time low was 4700 KRW and was reached on Mar 19, 2020.
See other stocks reaching their highest and lowest prices.

As of Apr 30, 2024, the company has 77.00 employees. See our rating of the largest employees — is OPTIPHARM on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So OPTIPHARM technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating OPTIPHARM stock shows the sell signal. See more of OPTIPHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OPTIPHARM EBITDA is ‪−1.20 B‬ KRW, and current EBITDA margin is −6.90%. See more stats in OPTIPHARM financial statements.